Target therapy of luminal HER2-negative advanced breast cancer with PIK3CA mutation: combination of alpelisib plus fulvestrant in real clinical practice
Filonenko, D. A., Ibragimova, T. M., Polshina, N. I., Belogurova, A. V., Khatkova, E. I., Arutiunian, E. A., Volkova, E. I., Zhukova, L. G.
Published in Medicinskij sovet (10.12.2021)
Published in Medicinskij sovet (10.12.2021)
Get full text
Journal Article